Trial Profile

An open lable multi-center study of ENT-01 in patients with Parkinson's Disease Dementia

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 26 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ENT 01 (Primary)
Indications Dementia; Parkinson's disease
Focus Adverse reactions
Acronyms DEMET

Most Recent Events

26 Jun 2019 New trial record
24 Jun 2019 According to an Enterin media release, trial design of this trial is same as Phase 2B (KARMET) study and will be conducted at 15 US sites including Georgetown University, University of Southern Florida and Penn State University and
24 Jun 2019 According to an Enterin media release, first patient has been enrolled in this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com